Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda Pring

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2025
Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell CarcinomaAndrew C L Lam, Katrina Hueniken, Martha Pienkowski, et al.
Cancer Research|August 30, 2016
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease EtiologyAndrew G Schache, Ned G Powell, Kate S Cuschieri, et al.
International Journal of Cancer|September 11, 2023
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sexJohannes M A Kusters, Brenda Diergaarde, Andrew Ness, et al.
Journal of the National Cancer Institute|September 19, 2023
Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysisJason Tasoulas, Douglas R Farquhar, Siddharth Sheth, et al.
American Journal of Cancer Research|December 11, 2024
The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinomaRoberta Pastorino, Denise Pires Marafon, Nicolò Lentini, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC StudyHisham Mehanna, Davy Rapozo, Sandra V von Zeidler, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Plos Genetics|April 22, 2021
Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization studyMark Gormley, James Yarmolinsky, Tom Dudding, et al.
BMC Medicine|January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomizationMark Gormley, Tom Dudding, Linda Kachuri, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2025
Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell CarcinomaAndrew C L Lam, Katrina Hueniken, Martha Pienkowski, et al.
Cancer Research|August 30, 2016
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease EtiologyAndrew G Schache, Ned G Powell, Kate S Cuschieri, et al.
International Journal of Cancer|September 11, 2023
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sexJohannes M A Kusters, Brenda Diergaarde, Andrew Ness, et al.
Journal of the National Cancer Institute|September 19, 2023
Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysisJason Tasoulas, Douglas R Farquhar, Siddharth Sheth, et al.
American Journal of Cancer Research|December 11, 2024
The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinomaRoberta Pastorino, Denise Pires Marafon, Nicolò Lentini, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC StudyHisham Mehanna, Davy Rapozo, Sandra V von Zeidler, et al.
Pageof 5